NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials
Putting Patients First Blog
SEPTEMBER 26, 2024
Disparities in clinical trial participation have been well-documented, with certain populations, particularly racial and ethnic minorities, women, pregnant and lactating people, older adults, and people with disabilities, often underrepresented in clinical research. NHC comments on FDA diversity in clinical trials guidance.
52 
Let's personalize your content